JP2009532457A5 - - Google Patents

Download PDF

Info

Publication number
JP2009532457A5
JP2009532457A5 JP2009503689A JP2009503689A JP2009532457A5 JP 2009532457 A5 JP2009532457 A5 JP 2009532457A5 JP 2009503689 A JP2009503689 A JP 2009503689A JP 2009503689 A JP2009503689 A JP 2009503689A JP 2009532457 A5 JP2009532457 A5 JP 2009532457A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
effective amount
cancer
biological condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009503689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009532457A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/003143 external-priority patent/WO2008035206A2/en
Publication of JP2009532457A publication Critical patent/JP2009532457A/ja
Publication of JP2009532457A5 publication Critical patent/JP2009532457A5/ja
Ceased legal-status Critical Current

Links

JP2009503689A 2006-04-06 2007-04-06 ２−メチレン−１α−ヒドロキシ−１８，１９，２１−トリノルビタミンＤ３類縁体およびその使用 Ceased JP2009532457A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74438106P 2006-04-06 2006-04-06
PCT/IB2007/003143 WO2008035206A2 (en) 2006-04-06 2007-04-06 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof

Publications (2)

Publication Number Publication Date
JP2009532457A JP2009532457A (ja) 2009-09-10
JP2009532457A5 true JP2009532457A5 (enExample) 2010-05-20

Family

ID=39200903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009503689A Ceased JP2009532457A (ja) 2006-04-06 2007-04-06 ２−メチレン−１α−ヒドロキシ−１８，１９，２１−トリノルビタミンＤ３類縁体およびその使用

Country Status (8)

Country Link
US (1) US8575136B2 (enExample)
EP (1) EP2001841B1 (enExample)
JP (1) JP2009532457A (enExample)
AU (1) AU2007298651A1 (enExample)
CA (1) CA2645185A1 (enExample)
MX (1) MX2008012672A (enExample)
NZ (1) NZ570712A (enExample)
WO (1) WO2008035206A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575136B2 (en) 2006-04-06 2013-11-05 Wisconsin Alumni Research Foundation 2-methylene-1α-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
US4666634A (en) * 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
US4970203A (en) * 1988-12-09 1990-11-13 Deluca Hector F Method for improving reproductive functions in mammals
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP2898882B2 (ja) * 1993-04-05 1999-06-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン ２−位に置換基を有する１９−ノル−ビタミンｄ３ 化合物
US5880114A (en) * 1993-06-16 1999-03-09 Wisconsin Alumni Research Foundation Treatment of immune deficiency with vitamin D compounds
US6291444B1 (en) * 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5825133A (en) * 1996-09-25 1998-10-20 Rockwell International Resonant inverter for hot cathode fluorescent lamps
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6306844B1 (en) * 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6382071B1 (en) * 2000-08-07 2002-05-07 Gilbert A. Bertani Bola capturing apparatus
AU7544501A (en) * 2000-09-08 2002-03-22 Wisconsin Alumni Res Found 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
US20030018017A1 (en) 2001-01-25 2003-01-23 Deluca Hector F. Method of treatment of type I diabetes
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
WO2003051828A2 (en) * 2001-12-13 2003-06-26 Wisconsin Alumni Research Foundation (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6566352B1 (en) * 2002-02-18 2003-05-20 Wisconsin Alumni Research Foudation 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
NZ542674A (en) * 2003-04-10 2009-03-31 Wisconsin Alumni Res Found 2-Propylidene-19-nor-vitamin D compounds
US20050009792A1 (en) 2003-07-08 2005-01-13 Deluca Hector F. (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
WO2005051396A2 (en) * 2003-11-25 2005-06-09 Deltanoid Pharmaceuticals, Inc. Methods for reducing body fat using vitamin d compounds
WO2005051323A2 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
US7713951B2 (en) * 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
WO2006057884A2 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES
US7803789B2 (en) * 2006-02-02 2010-09-28 Wisconsin Alumni Research Foundation Vitamin D analog—RAK, methods and uses thereof
US7528122B2 (en) * 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
US8575136B2 (en) 2006-04-06 2013-11-05 Wisconsin Alumni Research Foundation 2-methylene-1α-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
NZ570814A (en) * 2006-04-06 2011-11-25 Wisconsin Alumni Res Found 2-methylene-1alpha-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof
MX2010007956A (es) * 2008-01-22 2010-09-14 Wisconsin Alumni Reasearch Fou Analogos de 13,13-dimetil-des-c,d de compuestos de 1a,25-dihidroxi-19-nor-vitamina d3 y formas de dosificacion de composicion topica y metodos de tratamiento de condiciones de la piel.
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US8399439B2 (en) * 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
US20120283228A1 (en) * 2011-05-03 2012-11-08 Wisconsin Alumni Research Foundation 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses

Similar Documents

Publication Publication Date Title
JP2009532458A5 (enExample)
JP2010505739A5 (enExample)
JP2008520689A5 (enExample)
Wang et al. Effects of dietary zinc oxide nanoparticles on growth, diarrhea, mineral deposition, intestinal morphology, and barrier of weaned piglets
US7053075B2 (en) Methods for reducing body fat using vitamin D compounds
JP2005529878A5 (enExample)
JP2010504995A5 (enExample)
JP2007512376A (ja) 肥満症の予防及び治療用ビタミンｄ類似体
JP6383365B2 (ja) （２２Ｅ）−２−メチレン−２２−デヒドロ−１α，２４，２５−トリヒドロキシ−１９−ノル−ビタミンＤ３類似体
JP2009532458A (ja) ２−メチレン−１α−ヒドロキシ−１９，２１−ジノルビタミンＤ３類縁体およびその使用
JP2009533483A5 (enExample)
JP2008520705A5 (enExample)
JP2008520691A5 (enExample)
CA2588410A1 (en) 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
CA2588415A1 (en) 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
JP2013522369A5 (enExample)
JP2010504994A5 (enExample)
JP2011527695A5 (enExample)
JP2011527699A5 (enExample)
EP1015423B1 (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
JP2008530110A5 (enExample)
CA2531505A1 (en) (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
JP2009532457A5 (enExample)
JP2008520708A5 (enExample)
JP2011527696A5 (enExample)